Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCDNA3.1 (-) + SLNCR1 + 12x MS2 bs Citations (1)

Originally described in: The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region.
Schmidt K, Joyce CE, Buquicchio F, Brown A, Ritz J, Distel RJ, Yoon CH, Novina CD Cell Rep. 2016 May 31;15(9):2025-37. doi: 10.1016/j.celrep.2016.04.018. Epub 2016 May 19.
PubMed Journal

Articles Citing pCDNA3.1 (-) + SLNCR1 + 12x MS2 bs

Articles
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA. Hao Q, Wang P, Dutta P, Chung S, Li Q, Wang K, Li J, Cao W, Deng W, Geng Q, Schrode K, Shaheen M, Wu K, Zhu D, Chen QH, Chen G, Elshimali Y, Vadgama J, Wu Y. Cell Death Dis. 2020 Dec 11;11(12):1052. doi: 10.1038/s41419-020-03235-w. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.